N2-[(2R)-4-[(1,1-DiMethylethoxy)aMino]-2-(2-naphthalenylMethyl)-1,4-dioxobutyl]-N5-[[[2,3-dihydro-2,2,4,6,7-pentaMethyl-5-benzofuranyl]sulfonyl]aMino]iMinoethyl-L-ornithine

N2-[(2R)-4-[(1,1-DiMethylethoxy)aMino]-2-(2-naphthalenylMethyl)-1,4-dioxobutyl]-N5-[[[2,3-dihydro-2,2,4,6,7-pentaMethyl-5-benzofuranyl]sulfonyl]aMino]iMinoethyl-L-ornithine Chemische Eigenschaften,Einsatz,Produktion Methoden

• Verwenden

  Intermediate in the synthesis of substrate-selective peptide hydroxamate inhibitor of insulin-degrading enzyme, N2-[(2R)-4-(Hydroxyamino)-2-(2-naphthalenylmethyl)-1,4-dioxobutyl]-L-arginyl-L-tryptophyl-L-α-glutamine (H828110).

N2-[(2R)-4-[(1,1-DiMethylethoxy)aMino]-2-(2-naphthalenylMethyl)-1,4-dioxobutyl]-N5-[[[2,3-dihydro-2,2,4,6,7-pentaMethyl-5-benzofuranyl]sulfonyl]aMino]iMinoethyl-L-ornithine Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global(6)Suppliers